GMO strengthens equities line-up
Global investment management firm GMO has appointed three senior investment professionals to its Sydney-based Australian equities team.
Geoff Wells, Mark Thompson and Bradley Grehan are intended to “strengthen GMO’s global portfolio management, research and trading efforts”, according to GMO’s head of Australian equities Rick Suvak.
Formerly a senior portfolio manager at Macquarie Investment Management, Wells has been appointed as a senior quantitative research analyst, focusing primarily on alpha model research.
Thompson has also joined GMO as senior quantitative research analyst, and will also be concentrating on alpha model research.
He was previously a quantitative portfolio manager at State Street Global Advisors where he managed the group’s short enabled strategies (market-neutral, equitised long-short and 130/30 portfolios).
Grehan joins GMO as a senior portfolio trader, and will focus on trade execution while also participating in the management of GMO’s Australian equity portfolios.
He brings 12 years of industry and trading experience to GMO from Tolhurst, Morgan Stanley and JBWere.
Recommended for you
Investment manager Woodbridge Capital has appointed Ben Evans as executive director, origination, joining the firm from Metrics Credit Partners.
Revolution Asset Management has listed its Private Credit Income Trust on the ASX today, offering retail access to Australian and New Zealand private credit.
Northern Trust Asset Management has appointed Anwiti Bahuguna as global co-chief investment officer to succeed Michael Hunstad, who was recently named president of the firm.
Three managed investment schemes have received interim stop orders from ASIC following its private credit review, including two run by La Trobe Financial Asset Management.
